ClinicalTrials.gov
public full text
Public Domain
Chemoreflex Sensitivity in Chronic Kidney Disease
Cardiovascular morbidity and mortality are markedly increased in chronic kidney disease (CKD) and may be explained in part by sympathetic hyperactivity. Impaired hyperoxic chemoreflex sensitivity (CHRS) has been attributed to an increased sympathetic activity. The aim of the present study is to examine whether chemosensor function is altered in patients with stage 3 and stage 4 CKD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension#373706
- Peritoneal Ultrafiltration to Treat Congestive Heart Failure#901929
- Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients#1095443
- PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION#826393
- The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.#1162340
Record · ID 1365353
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive